Inspire Pharmaceuticals Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Raleigh NC United States (1993)
Status: Acquired by Merck (2011)

Organization Overview

First Clinical Trial
2008
NCT00767793
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Medical Monitor, Inspire

Active Ingredients

Drugs in Phase 3 Trials (1)

ins365 (1 trial)

Drugs in Phase 2 Trials (1)

azithromycin (zithromax) (2 trials)

Drugs in Phase 1 Trials (1)

pilocarpine (ocusert) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Blepharitis (Phase 2)

Dry Eye Syndromes (Phase 3)

Eye Diseases (Phase 3)

Glaucoma (Phase 1)

Keratoconjunctivitis Sicca (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 3